Apriem Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-124
Closed -$5K 171
2017
Q1
$5K Hold
124
﹤0.01% 471
2016
Q4
$5K Hold
124
﹤0.01% 489
2016
Q3
$4K Hold
124
﹤0.01% 472
2016
Q2
$4K Hold
124
﹤0.01% 482
2016
Q1
$4K Hold
124
﹤0.01% 450
2015
Q4
$4K Hold
124
﹤0.01% 447
2015
Q3
$4K Sell
124
-62
-33% -$2.16K ﹤0.01% 426
2015
Q2
$8K Buy
186
+62
+50% +$2.78K ﹤0.01% 430
2015
Q1
$6K Hold
124
﹤0.01% 453
2014
Q4
$6K Buy
+124
New +$4.87K ﹤0.01% 412

Other funds holding AVNS

Apriem Advisors's AVNS Position: Q2 2017 in Review

Apriem Advisors sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 124 shares — an estimated $5K sold.

Apriem Advisors first reported a position in AVNS in Q4 2014 and held it in 10 quarters. The position peaked at $8K in Q2 2015. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Apriem Advisors reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
  • Apriem Advisors sold 124 Avanos Medical shares in Q2 2017, an estimated $5K.
  • Apriem Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 10 quarters.
  • Apriem Advisors's Avanos Medical position peaked at $8K in Q2 2015.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.